Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
[Preprint]. 2025 May 28:2025.05.27.25328425.
doi: 10.1101/2025.05.27.25328425.

Multidimensional Modeling to Maximize Adaptations to eXercise: The M3AX Trial Rationale and Study Design

Affiliations

Multidimensional Modeling to Maximize Adaptations to eXercise: The M3AX Trial Rationale and Study Design

Zachary A Graham et al. medRxiv. .

Update in

  • Multidimensional Modeling to Maximize Adaptations to eXercise: The M3AX Trial Rationale and Study Design.
    Graham ZA, Bubak MP, Raymond-Pope CJ, Cutter GR, McAdam JS, Tuggle SC, Siedlik JA, de Sousa LGO, Chappe EJ, Meece K, Kaur A, Ruiz BSR, Bamman SC, Vanselow KM, Perry TW, Acosta-Arreguin JS, Bohmke NJ, Addison GJ, Bowers JM, Wright RL, Fuentes LD, Smith JE, Esser KA, Miller BF, Bodine SC, Bamman MM. Graham ZA, et al. J Appl Physiol (1985). 2025 Sep 27. doi: 10.1152/japplphysiol.00486.2025. Online ahead of print. J Appl Physiol (1985). 2025. PMID: 41015496

Abstract

Age-related functional declines are thought to be caused by hallmark biological processes that manifest in physical, mental, and metabolic impairments compromising intrinsic capacity, healthspan and quality-of-life. Exercise is a multipotent treatment with promise to mitigate most aging hallmarks, but there is substantial variability in individual exercise responsiveness. This inter-individual response heterogeneity (IRH) was first extensively interrogated by Bouchard and colleagues in the context of endurance training. Our group has interrogated IRH in response to resistance training and combined training, and we have conducted trials in older adults examining dose titration and adjuvant treatments in attempts to boost response rates. Despite the work of many groups, the mechanisms underpinning IRH and effective mitigation strategies largely remain elusive. The National Institute on Aging (NIA) hosted a focused workshop in 2022 titled "Understanding heterogeneity of responses to, and optimizing clinical efficacy of, exercise training in old adults". This workshop spurred a dedicated NIA request for applications (RFA) with the major goal "to better understand factors underlying response variability to exercise training in older adults." We developed a two-phase Sequential Multiple Assignment Randomized Trial (SMART) in response to the RFA that will allow us to classify individual responsiveness to combined endurance and resistance training and interrogate potential mechanistic underpinnings (Phase I), followed by an approach to boost responsiveness (Phase II). Using deep in vivo, ex vivo, and molecular phenotyping, we will establish multidimensional biocircuitry of responsiveness and build predictive models, providing a basis for personalized exercise prescriptions.

Keywords: Combined Training; Geroscience; Heterogeneity; Skeletal Muscle.

PubMed Disclaimer

Conflict of interest statement

Conflicts of Interest G.R.C: Data and Safety Monitoring Boards: Applied Therapeutics, AI therapeutics, AMO Pharma, Argenx, Astra-Zeneca, Avexis Pharmaceuticals, Bristol Meyers Squibb, CSL Behring, Cynata Therapeutics, DiamedicaTherapeutics, Horizon Pharmaceuticals, Immunic, Inhibrix, Karuna Therapeutics, Kezar Life Sciences, Medtronic, Merck, Meiji Seika Pharma, Mitsubishi Tanabe Pharma Holdings, Prothena Biosciences, Novartis, Pipeline Therapeutics (Contineum), Regeneron, Sanofi-Aventis, Teva Pharmaceuticals, United BioSource LLC, University of Texas Southwestern. Consulting or Advisory Boards: Alexion, Antisense Therapeutics/Percheron, Avotres, Biogen, Clene Nanomedicine, Clinical Trial Solutions LLC, Endra Life Sciences, Cognito Therapeutics, Genzyme, Genentech, Hoya Corporation, Immunic, Immunosis Pty Ltd, Klein-Buendel Incorporated, Kyverna Therapeutics, Inc. , Linical, Merck/Serono, Noema, Perception Neurosciences, Protalix Biotherapeutics, Regeneron, Revelstone Consulting, Roche, SAB Biotherapeutics, Sapience Therapeutics, Scott&Scott LLP, Tenmile. Dr. Cutter is employed by IHMC, University of Alabama at Birmingham and President of Pythagoras, Inc. a private consulting company located in Birmingham AL.

Figures

Fig. 1.
Fig. 1.
Using the traditional clinical and rehabilitative practice of calculating MICDs to track progress or define treatment/intervention efficacy, we leveraged data from our previous large-scale combined ET+RT clinical trial in young individuals to generate MCIDs of exercise responsiveness. We selected an established distribution-based method to generate MCIDs based on % change from pre- to post-12 weeks of training for A) cardiorespiratory fitness (CRF) and B) functional muscle quality (fMQ). These MCID criteria generated the expected responder breakdown (‘−‘ = did not meet MCID, ‘+’ met MCID shown in the Punnet Square shown in C).
Fig. 2.
Fig. 2.
Overall trial design. The 2-phase SMART design is intended to determine what factors and mechanisms underlie inter-individual exercise response heterogeneity (IRH) among older adults. We employ a rigorous exercise prescription of combined endurance and resistance training to ensure direct translatability to public health recommendations. Phase I (12 week) is focused on interrogation which involves testing targeted hypotheses anchored to hallmarks of aging complemented by a multidimensional learning framework to decipher complex interrelationships among clinical, molecular, and behavioral phenotyping. Our modeling framework will produce integrated, multidimensional circuits predictive of responsiveness that contain modifiable factors for future study and precision exercise medicine. Phase II (10 week) will attempt mitigation by a targeted augmentation strategy for the older adults who do not attain minimum clinically important difference (MCID) scores for one or both primary outcomes (CRF and fMQ). Those in Phase II who meet both MCIDs will be randomized to test sustainability of training adaptations during free-living (vs. continuing the supervised intervention). Planned enrollment is therefore N=250 to account for up to 20% data missingness (data loss, QA/QC, attrition).
Fig. 3.
Fig. 3.
General participant flowthrough and expected burden from screening through end of the study.
Fig. 4:
Fig. 4:
Multidimensional learning framework to model and predict inter-individual exercise response heterogeneity. Step 1: Model inputs are curated independently within each data set, with each variable considered a feature. Step 2: Multidimensional, integrated phenomic, cellular, molecular multiomic and inter-tissue communication circuitry established using Recurrent Convolutional Neural Networks (RCNN). Baseline and longitudinal data from across domains (e.g., physical performance, molecular signatures) are concatenated and passed through a 1D convolutional layer to extract local temporal patterns. The output is then fed into parallel Long Short-Term Memory (LSTM) layers to capture sequential dependencies and temporal dynamics. Step 3: Outputs from each LSTM stream are fused and passed to a final dense output layer for identification of key features as determined using SHapley Additive exPlanations (SHAP) values. Step 4: Selected impactful features are based on two relevant criteria: good fit (i.e., high SHAP values) and actionable/modifiable. The most influential based on strength of relationship with responder classification will serve as inputs for predictive modeling of responsiveness.

References

    1. Granic A, Suetterlin K, Shavlakadze T, Grounds MD, Sayer AA. Hallmarks of ageing in human skeletal muscle and implications for understanding the pathophysiology of sarcopenia in women and men. Clin Sci (Lond). 2023;137(22):1721–1751. doi: 10.1042/CS20230319 - DOI - PMC - PubMed
    1. US Census Bureau. U.S. Older Population Grew From 2010 to 2020 at Fastest Rate Since 1880 to 1890. Census.gov. Accessed February 10, 2025. https://www.census.gov/library/stories/2023/05/2020-census-united-states...
    1. Lee J, Song RJ, Musa Yola I, et al. Association of Estimated Cardiorespiratory Fitness in Midlife With Cardiometabolic Outcomes and Mortality. JAMA Netw Open. 2021;4(10):e2131284. doi: 10.1001/jamanetworkopen.2021.31284 - DOI - PMC - PubMed
    1. Pettee Gabriel K, Jaeger BC, Lewis CE, et al. Analysis of Cardiorespiratory Fitness in Early Adulthood and Midlife With All-Cause Mortality and Fatal or Nonfatal Cardiovascular Disease. JAMA Netw Open. 2023;6(2):e230842. doi: 10.1001/jamanetworkopen.2023.0842 - DOI - PMC - PubMed
    1. Mandsager K, Harb S, Cremer P, Phelan D, Nissen SE, Jaber W. Association of Cardiorespiratory Fitness With Long-term Mortality Among Adults Undergoing Exercise Treadmill Testing. JAMA Netw Open. 2018;1(6):e183605. doi: 10.1001/jamanetworkopen.2018.3605 - DOI - PMC - PubMed

Publication types

LinkOut - more resources